English
Regional settings| Spread | 5.60 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ JP¥5,000 Short position overnight fee ~ JP¥4,000 | -0.011244% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ JP¥5,000 Short position overnight fee ~ JP¥4,000 | -0.010978% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | JPY | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Japan | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 893.36 |
| Open | 884.87 |
| 1-Year Change | 11.65% |
| Day's Range | 883.98 - 897.35 |
Mitsubishi Chemical Holdings Corporation is a Japan-based company engaged in the functional products, healthcare and materials business. The Company operates through four business segments. The Functional Products segment is involved in functional materials business and functional chemistry business. Products of functional materials business include electro-electric displays, high-performance films, high-performance molding materials, environment solutions and life solutions. Products of functional chemicals business include high functional polymers, high functional chemicals and new energy. The Chemicals segment is engaged in Methyl methacrylate (MMA) business, petrochemical business and carbon business. The Industrial Gas segment is engaged in the manufacture and sale of industrial gas. The Healthcare segment offers pharmaceuticals, diagnosis products and clinical inspection services. The Company is also engaged in engineering businesses.
BRIEF: For the nine months ended 31 December 2021, Mitsubishi Chemical Holdings Corp. revenues increased 23% to Y2.9T. Net income totaled Y122.13B vs. loss of Y47.83B. Revenues reflect Chemicals segment increase of 52% to Y921.84B, Functional Chemical segment increase of 14% to Y848.86B, Japan segment increase of 18% to Y1.54T, Asia segment increase of 25% to Y571.21B. Net Income reflects Impairment Loss decrease of 93% to Y8.01B (expense).
Common Stock No Par, 3/06, Unlim. Auth. 1,370,090,113 o/s, net of shares in Treas. @ Y120.12B. FY'05&06 Q3 WAS & O/S were estimated. FY'08's WAS & DWAS were estimated and WAS=O/S. FY'09 2Q,12q2,q3 DWAS was estimated.
